ATE230745T1 - Polycyclische azaindolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Polycyclische azaindolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number: ATE230745T1
Authority: AT; Austria
Prior art keywords: alkyl; group; alkoxy; polyhaloalkyl; optionally substituted
Prior art date: 1999-10-15

Application number

AT00402832T

Other languages

English (en)

Inventor

Gerald Guillaumet

Marie-Claude Viaud

De Poel Herve Van

Philippe Delagrange

Caroline Bennejean

Pierre Renard

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2000-10-13

Publication date

2003-01-15

2000-10-13 Application filed by Servier Lab filed Critical Servier Lab

2003-01-15 Application granted granted Critical

2003-01-15 Publication of ATE230745T1 publication Critical patent/ATE230745T1/de

Links

238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 7
125000003545 alkoxy group Chemical group 0.000 abstract 5
229910052736 halogen Inorganic materials 0.000 abstract 4
150000002367 halogens Chemical class 0.000 abstract 4
125000006684 polyhaloalkyl group Polymers 0.000 abstract 4
125000001072 heteroaryl group Chemical group 0.000 abstract 3
125000004043 oxo group Chemical group O=* 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000003368 amide group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
-1 diastereoisomers Chemical class 0.000 abstract 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
239000000543 intermediate Substances 0.000 abstract 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
125000004193 piperazinyl group Chemical group 0.000 abstract 2
125000003367 polycyclic group Chemical group 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000000719 pyrrolidinyl group Chemical group 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
235000010290 biphenyl Nutrition 0.000 abstract 1
239000004305 biphenyl Substances 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000002993 cycloalkylene group Chemical group 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
125000001041 indolyl group Chemical group 0.000 abstract 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000003386 piperidinyl group Chemical group 0.000 abstract 1
125000003373 pyrazinyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
125000005493 quinolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)

AT00402832T 1999-10-15 2000-10-13 Polycyclische azaindolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE230745T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9912900A FR2799757B1 (fr)	1999-10-15	1999-10-15	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ATE230745T1 true ATE230745T1 (de)	2003-01-15

Family

ID=9550991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00402832T ATE230745T1 (de)	1999-10-15	2000-10-13	Polycyclische azaindolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (22)

Country	Link
US (3)	US6495543B1 (de)
EP (1)	EP1092717B1 (de)
JP (1)	JP3519357B2 (de)
KR (1)	KR100460783B1 (de)
CN (1)	CN1151152C (de)
AT (1)	ATE230745T1 (de)
AU (1)	AU772126B2 (de)
BR (1)	BR0004823A (de)
CA (1)	CA2323720C (de)
DE (1)	DE60001138T2 (de)
DK (1)	DK1092717T3 (de)
EA (1)	EA003666B1 (de)
ES (1)	ES2189730T3 (de)
FR (1)	FR2799757B1 (de)
HU (1)	HUP0004007A3 (de)
MX (1)	MXPA00009729A (de)
NO (1)	NO317884B1 (de)
NZ (1)	NZ507525A (de)
PL (1)	PL343187A1 (de)
PT (1)	PT1092717E (de)
SI (1)	SI1092717T1 (de)
ZA (1)	ZA200005667B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6269533B2 (en) *	1999-02-23	2001-08-07	Advanced Research Corporation	Method of making a patterned magnetic recording head
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1132389A1 (de) *	2000-03-06	2001-09-12	Vernalis Research Limited	Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit
DE10143079A1 (de) *	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
US20050267303A1 (en) *	2001-09-04	2005-12-01	Zentaris Ag	Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
GB0202015D0 (en) *	2002-01-29	2002-03-13	Hoffmann La Roche	Piperazine Derivatives
US7595311B2 (en) *	2002-05-24	2009-09-29	Exelixis, Inc.	Azepinoindole derivatives as pharmaceutical agents
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7507835B2 (en)	2002-11-28	2009-03-24	Suven Life Sciences Ltd.	N-arylsulfonyl-3-aminoalkoxyindoles
JP4571507B2 (ja) *	2002-12-18	2010-10-27	スベンライフサイエンシズリミティド	セロトニン受容体親和性を有する四環系３−置換インドール
DE202007014474U1 (de) *	2007-10-16	2009-03-05	Schwan-Stabilo Cosmetics Gmbh & Co. Kg	Aufgespritzte Applikatoren
BRPI0916395A2 (pt) *	2008-07-30	2016-02-16	Ferrer Int	compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
WO2010031184A1 (en) *	2008-09-22	2010-03-25	Merck Frosst Canada Ltd.	Azaindole derivatives as crth2 receptor antagonists

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3910901A (en) *	1972-02-14	1975-10-07	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US3912729A (en) *	1972-02-14	1975-10-14	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US3962236A (en) *	1972-02-14	1976-06-08	Ayerst Mckenna And Harrison Ltd.	Oxazinoindole- and thiazinoindole derivatives
US3910903A (en) *	1974-02-14	1975-10-07	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US4012511A (en) *	1974-05-28	1977-03-15	Ayerst Mckenna & Harrison Ltd.	Oxazinoindole derivatives useful as antidepressants
US4066763A (en) *	1975-07-07	1978-01-03	Ayerst Mckenna And Harrison Ltd.	Thiazinoindoles useful as antidepressants
EP0183993A3 (de) *	1984-11-16	1987-12-09	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
EP0195745B1 (de) *	1985-03-12	1990-09-12	Ciba-Geigy Ag	Heterocyclisch kondensierte Pyridin-Verbindungen als Herbizide
DK155524C (da) *	1987-03-18	1989-09-11	Ferrosan As	Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
EP0572863A1 (de) *	1992-06-05	1993-12-08	F. Hoffmann-La Roche Ag	ZNS Pyrazinoindole
MX9305947A (es) *	1992-09-29	1994-06-30	Smithkline Beecham Plc	Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
FR2732969B1 (fr) *	1995-04-14	1997-05-16	Adir	Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2762598A1 (fr) *	1997-04-25	1998-10-30	Adir	Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent
FR2763335B1 (fr) *	1997-05-16	2000-11-24	Adir	Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2766824B1 (fr) *	1997-07-30	1999-09-10	Adir	Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9902047D0 (en) *	1999-01-29	1999-03-17	Cerebrus Ltd	Chemical compounds XI
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019117D0 (en) *	2000-08-03	2000-09-27	Univ Barcelona	Derivatives of variolin B
EP1561159A4 (de) *	2002-11-12	2007-08-29	Zetera Corp	Elektrische einrichtungen mit verbesserter kommunikation

1999
- 1999-10-15 FR FR9912900A patent/FR2799757B1/fr not_active Expired - Fee Related
2000
- 2000-10-04 MX MXPA00009729A patent/MXPA00009729A/es active IP Right Grant
- 2000-10-12 US US09/689,578 patent/US6495543B1/en not_active Expired - Fee Related
- 2000-10-13 AT AT00402832T patent/ATE230745T1/de not_active IP Right Cessation
- 2000-10-13 CA CA002323720A patent/CA2323720C/fr not_active Expired - Fee Related
- 2000-10-13 EP EP00402832A patent/EP1092717B1/de not_active Expired - Lifetime
- 2000-10-13 AU AU66502/00A patent/AU772126B2/en not_active Ceased
- 2000-10-13 HU HU0004007A patent/HUP0004007A3/hu unknown
- 2000-10-13 PT PT00402832T patent/PT1092717E/pt unknown
- 2000-10-13 NZ NZ507525A patent/NZ507525A/en unknown
- 2000-10-13 JP JP2000314109A patent/JP3519357B2/ja not_active Expired - Fee Related
- 2000-10-13 BR BR0004823-2A patent/BR0004823A/pt not_active Application Discontinuation
- 2000-10-13 CN CNB001304739A patent/CN1151152C/zh not_active Expired - Fee Related
- 2000-10-13 ZA ZA200005667A patent/ZA200005667B/xx unknown
- 2000-10-13 SI SI200030043T patent/SI1092717T1/xx unknown
- 2000-10-13 PL PL00343187A patent/PL343187A1/xx not_active Application Discontinuation
- 2000-10-13 ES ES00402832T patent/ES2189730T3/es not_active Expired - Lifetime
- 2000-10-13 EA EA200000948A patent/EA003666B1/ru not_active IP Right Cessation
- 2000-10-13 DK DK00402832T patent/DK1092717T3/da active
- 2000-10-13 DE DE60001138T patent/DE60001138T2/de not_active Expired - Fee Related
- 2000-10-16 KR KR10-2000-0060725A patent/KR100460783B1/ko not_active Expired - Fee Related
- 2000-10-16 NO NO20005200A patent/NO317884B1/no not_active IP Right Cessation
2002
- 2002-10-09 US US10/267,238 patent/US6667304B2/en not_active Expired - Fee Related
- 2002-10-09 US US10/267,303 patent/US7235550B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1151152C (zh)	2004-05-26
EA003666B1 (ru)	2003-08-28
CA2323720A1 (fr)	2001-04-15
EP1092717A2 (de)	2001-04-18
NO317884B1 (no)	2004-12-27
HUP0004007A3 (en)	2002-06-28
DE60001138T2 (de)	2003-10-23
BR0004823A (pt)	2001-05-22
EP1092717B1 (de)	2003-01-08
US20030134847A1 (en)	2003-07-17
KR20010067334A (ko)	2001-07-12
AU772126B2 (en)	2004-04-08
DE60001138D1 (de)	2003-02-13
US20030105087A1 (en)	2003-06-05
KR100460783B1 (ko)	2004-12-09
NO20005200D0 (no)	2000-10-16
US6667304B2 (en)	2003-12-23
CN1293195A (zh)	2001-05-02
NO20005200L (no)	2001-04-17
SI1092717T1 (en)	2003-04-30
EA200000948A1 (ru)	2001-04-23
NZ507525A (en)	2001-09-28
US7235550B2 (en)	2007-06-26
AU6650200A (en)	2001-04-26
CA2323720C (fr)	2005-02-15
PL343187A1 (en)	2001-04-23
FR2799757A1 (fr)	2001-04-20
PT1092717E (pt)	2003-04-30
JP3519357B2 (ja)	2004-04-12
HU0004007D0 (en)	2000-12-28
ZA200005667B (en)	2001-05-15
US6495543B1 (en)	2002-12-17
JP2001114781A (ja)	2001-04-24
ES2189730T3 (es)	2003-07-16
HK1036061A1 (en)	2001-12-21
FR2799757B1 (fr)	2001-12-14
EP1092717A3 (de)	2001-10-04
DK1092717T3 (da)	2003-04-14
HUP0004007A2 (hu)	2001-05-28
MXPA00009729A (es)	2002-06-04

Legal Events

Date

Code

Title

Description

2003-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1092717

Country of ref document: EP

2010-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60001138D1 (de)	2003-02-13	Polycyclische Azaindolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
AR018204A1 (es)	2001-10-31	METODO PARA LA PREPARACIOON DE CITALOPRAM , INTERMEDIARIO PARA LA PREPARACION DE CITALOPRAM Y EL USO DEL INTERMEDIARIO PARA LA PREPARACIoN DE CITALOPRAM
EA200400944A1 (ru)	2005-04-28	Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
AR036606A1 (es)	2004-09-22	Tratamiento con antranilamidas artropodicidas
AR035234A1 (es)	2004-05-05	Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento
KR927003052A (ko)	1992-12-17	2-아릴티아졸 유도체 및 그의 약제학적 조성물
AR014448A1 (es)	2001-02-28	Compuesto de alanina, una composicion farmaceutica, uso del compuesto y proceso para la preparacion del compuesto
CY1108339T1 (el)	2014-02-12	Παραγωγα spiro(2h-1-benzopyran-2,4´-piperidine) ως αναστολεις της μεταφορας γλυκινης
AR044502A1 (es)	2005-09-14	Quinazolinas utiles como moduladores de canales ionicos
CO5080780A1 (es)	2001-09-25	Derivado de amida y antagonista de nociceptina
AR081807A2 (es)	2012-10-24	Composiciones insecticidas sinergicas, metodo para el control de insectos, metodo para la proteccion de una planta contra la infestacion y ataque de insectos, y usos de las composiciones
WO2000029378A3 (en)	2000-12-14	Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
ECSP045073A (es)	2004-05-28	Nuevos derivados de piperazina
BG102715A (bg)	1999-08-31	Нови производни на арилглицинамид, метод за получаването им и фармацевтични състави съдържащи, ги
BR1100061A (pt)	2000-04-18	Composto, processo para a preparação do mesmo, composição e uso dos mesmos
CA2169737A1 (en)	1995-02-23	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
ATE227712T1 (de)	2002-11-15	Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen
CY1105752T1 (el)	2010-12-22	Παραγωγα ιμιδαζοπυριδινης μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
AR005233A1 (es)	1999-04-28	Derivados de 1,2,3,4-tetrahidroquinolina, procesos para su preparacion, una composicion farmaceutica y el uso en la elaboracion de un medicamento
AR045796A1 (es)	2005-11-16	Derivados de hexa y octahidro - pirido (1,2-a) pirazina con actividad antagonista de nk1. composiciones farmaceuticas.
NO974563L (no)	1997-11-24	Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO20005807L (no)	2001-05-21	Nye kamptotekinanaloge forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
FR2795071B1 (fr)	2001-07-27	Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB1070333A (en)	1967-06-01	New quinolone derivatives and compositions comprising them
GEP20084296B (en)	2008-01-25	Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same